BIROn - Birkbeck Institutional Research Online

    The HPV cellular transactivator Brn-3a can be used to predict cervical adenocarcinoma and squamous carcinoma precancer lesions in the developed and developing worlds

    Ndisang, D. and Lorenzato, F. and Sindos, M. and Khan, A. and Singer, A. and Latchman, David S. (2009) The HPV cellular transactivator Brn-3a can be used to predict cervical adenocarcinoma and squamous carcinoma precancer lesions in the developed and developing worlds. Obstetrics and Gynecology International , ISSN 1687-9589.

    [img]
    Preview
    Text
    4765.pdf - Published Version
    Available under License Creative Commons Attribution.

    Download (568kB) | Preview

    Abstract

    The cellular transactivator Brn-3a has previously been shown to be expressed at elevated levels in the cervix of women with squamous cell carcinoma of the cervix (SCC) and to activate the expression of HPV E6 mRNA. In this study, we show that common and rare cervical precancer lesions, including those of adenocarcinoma (AC), which are usually difficult to diagnose using classical procedures, also expressed high levels of Brn-3a and can be diagnosed by measuring the levels of Brn-3a and E6 mRNAs.

    Metadata

    Item Type: Article
    School: Central Administration Departments > Master's Office
    Depositing User: Sarah Hall
    Date Deposited: 14 Jun 2012 10:19
    Last Modified: 17 Apr 2013 12:33
    URI: http://eprints.bbk.ac.uk/id/eprint/4765

    Statistics

    Downloads
    Activity Overview
    271Downloads
    91Hits

    Additional statistics are available via IRStats2.

    Archive Staff Only (login required)

    Edit/View Item Edit/View Item